R&D

R&D is
the heart of our mission to develop global medicines for incurable diseases.

About R&D

Bio Research Center

Central Research Center

Seoul Research Center

HPI

What does each research institute studying about?

Bio Research
Center
  • Anti-TNF biologic drugs for inflammatory eye diseases
  • Novel antibody drugs for IgG-mediated autoimmune diseases
Seoul Research Center
  • Local regulatory affairs
  • Local clinical studies
  • Planning small molecule drug-development strategies
Central Research Center
  • Candidate screenings and selections
  • Efficacy estimations in clinical settings
  • Exploration of optimal combinations for unmet needs
HPI
Office in the U.S.
  • International licensing
  • Clinical Trials
  • Business & Development
R&D Fields바로가기